SYZONC, INC
SBIR award from Department of Health and Human Services.
Summary
SYZONC, INC received about $355,000 from the National Institutes of Health for an SBIR concept award. The project explores targeting the PLOD2 protein to treat undifferentiated pleomorphic sarcoma, a type of soft tissue cancer.
- Amount
- $354,878
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- PA
- Period
- 2025-09-29 → 2026-09-28
Technology domains
Human Performance & Medical
Description
SBIR FY25 CONCEPT AWARD, TARGETING PLOD2 IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA